tezosentan has been researched along with Injury, Ischemia-Reperfusion in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Korolkiewicz, RP; Sein-Anand, J; Sokołowska-Wojdyło, M; Umer, A; Włodarkiewicz, A; Ługowska-Umer, H | 1 |
Beier, UH; Chin, A; Fornell, L; John, E; Pham, J; Radhakrishnan, J; Samuel, S | 1 |
Gülmen, S; Kiris, I; Narin, C; Sütcü, R; Toy, H; Yilmaz, N | 1 |
Anselmo, D; Busuttil, RW; Clozel, M; Farmer, DG; Kaldas, F; Kaldas, M; Katori, M; Kupiec-Weglinski, J; Lassman, C; Shen, XD | 1 |
Ceylan, BG; Gulmen, S; Kiris, I; Mermi, B; Meteoglu, I; Narin, C; Sutcu, R | 1 |
Cho, KR; Jo, WM; Kim, HJ; Ryu, SM | 1 |
Robinson, AV; Schulak, JA; Stowe, NT; Wilhelm, SM | 1 |
7 other study(ies) available for tezosentan and Injury, Ischemia-Reperfusion
Article | Year |
---|---|
Endothelin receptor blockers protect against ischemia/reperfusion impairment of gastrointestinal motility in rats.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Carbachol; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Ether; Evans Blue; Gastrointestinal Motility; Male; Muscarinic Agonists; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Surgical Procedures, Operative; Tetrazoles | 2008 |
The effect of tezosentan after cold ischemia and renal artery clamping as a model of reperfusion injury in newborn piglets.
Topics: Animals; Animals, Newborn; Blood Flow Velocity; Cardiovascular System; Disease Models, Animal; Femoral Artery; Heart Rate; Ischemia; Pyridines; Renal Artery; Reperfusion Injury; Swine; Tetrazoles; Vasodilator Agents | 2008 |
Endothelin receptor blockade with tezosentan ameliorates myocardial injury induced by abdominal aortic ischemia-reperfusion.
Topics: Abdomen; Animals; Aorta; Endothelin Receptor Antagonists; Myocardial Infarction; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Tetrazoles | 2008 |
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.
Topics: Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hemodynamics; Ischemia; Liver; Liver Transplantation; Male; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tetrazoles; Warm Ischemia | 2008 |
Tezosentan reduces the renal injury induced by abdominal aortic ischemia-reperfusion in rats.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Aortic Diseases; Catalase; Endothelin Receptor Antagonists; Female; Kidney Glomerulus; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Oxidative Stress; Peroxidase; Postoperative Complications; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Tetrazoles; Vasodilator Agents | 2009 |
Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.
Topics: Animals; Cardiomyopathies; Coronary Vessels; Disease Models, Animal; Doxorubicin; Endothelin Receptor Antagonists; Heart Failure; Hypertrophy; Male; Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Reperfusion Injury; Tetrazoles; Vasodilator Agents; Ventricular Function, Left | 2009 |
The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function.
Topics: Animals; Endothelin Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Immunohistochemistry; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Tetrazoles; Time Factors | 2001 |